1. Home
  2. CAH vs NTRA Comparison

CAH vs NTRA Comparison

Compare CAH & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardinal Health Inc.

CAH

Cardinal Health Inc.

HOLD

Current Price

$222.49

Market Cap

55.6B

Sector

Health Care

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$417.26

Market Cap

47.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAH
NTRA
Founded
1979
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.6B
47.4B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
CAH
NTRA
Price
$222.49
$417.26
Analyst Decision
Buy
Strong Buy
Analyst Count
12
15
Target Price
$232.27
★ $259.07
AVG Volume (30 Days)
★ 1.4M
1.3M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
★ 1.01%
N/A
EPS Growth
★ 12.09
0.65
EPS
★ 7.23
N/A
Revenue
★ $254,248,000,000.00
$210,939,000.00
Revenue This Year
$17.36
$18.08
Revenue Next Year
$9.06
$19.65
P/E Ratio
$30.70
★ N/A
Revenue Growth
★ 14.23
N/A
52 Week Low
$150.78
$157.43
52 Week High
$258.30
$421.64

Technical Indicators

Market Signals
Indicator
CAH
NTRA
Relative Strength Index (RSI) 36.63 83.32
Support Level $220.37 $187.64
Resistance Level $222.58 N/A
Average True Range (ATR) 4.91 13.40
MACD -1.39 5.24
Stochastic Oscillator 20.69 90.98

Price Performance

Historical Comparison
CAH
NTRA

About CAH Cardinal Health Inc.

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: